to determine the effects of bay-m-1099 , a new alpha-glucosidase inhibitor , on insulin requirements and prandial glucose tolerance in patients with insulin-dependent diabetes mellitus ( iddm ) , plasma glucose , triglyceride , and free insulin concentrations were measured after ingestion of a standard breakfast , lunch , and dinner in nine patients with iddm in a single-blind , randomized , crossover design .
C0021641
insulin
C0011854
iddm